A company co-founded by Vanderbilt University professors has received a special designation from the U.S. Food and Drug Administration for a breakthrough device.
The designation streamlines the regulatory process for certain medical devices that provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases. In this case, the designation is for a technology developed by Nashville-based EndoTheia that increases the flexibility and usefulness of standard endoscopes, according to a news release from the school.
Robert J. Webster III, a professor of mechanical engineering and associate professor of medicine and urology, is also EndoTheia president. Another Vanderbilt professor, S. Duke Herrell III, is chief medical officer. The pair also co-founded Vanderbilt’s Institute for Surgery and Engineering, along with others. Caleb Rucker, who leads the REACH robotics lab at the University of Tennessee-Knoxville, is the chief scientific officer.
Republished with permission from The Associated Press.